首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial
【2h】

Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial

机译:在出生后第一年每天全身使用润肤剂预防高危儿童特应性湿疹的有效性和成本效益(BEEP试验):一项随机对照试验的方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAtopic eczema (AE) is a common skin problem that impairs quality of life and is associated with the development of other atopic diseases including asthma, food allergy and allergic rhinitis. AE treatment is a significant cost burden for health care providers. The purpose of the trial is to investigate whether daily application of emollients for the first year of life can prevent AE developing in high-risk infants (first-degree relative with asthma, AE or allergic rhinitis).
机译:背景特应性湿疹(AE)是一种常见的皮肤问题,会损害生活质量,并与其他特应性疾病(包括哮喘,食物过敏和过敏性鼻炎)的发展有关。 AE治疗对医疗保健提供者来说是巨大的成本负担。该试验的目的是调查在高危婴儿(哮喘,AE或过敏性鼻炎的一级亲属)中每天应用润肤剂是否可以预防AE的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号